In 2017, a newly established startup emerged as a significant player in the poultry nutrition industry and a potential rival to the multinational corporations that have long dominated the market. The company focused on developing animal nutritional solutions specifically for poultry.
The poultry nutrition segment’s most rapidly expanding Indian company, Glamac International Pvt. Ltd, achieved another significant accomplishment by being named the “Emerging Veterinary Pharma Company of the Year” at the 3rd Economic Times India Pharma World Awards (ETIPWA) in 2023. The awards ceremony, which was held at Mumbai’s Hotel Taj Santacruz, was a grand and impressive affair.
Being acknowledged as the primary “Emerging Veterinary Pharma Company of the Year” at the ET Health World Summit in just five years marks another crucial step for Glamac International Pvt. Ltd towards gaining recognition as one of the dominant contenders in the highly competitive animal nutrition industry, particularly in poultry.
The award recognized outstanding achievements and innovation in the Indian pharmaceutical industry, highlighting top-performing health, nutrition, and medicine organizations. It was designed to honor individuals, teams, and companies who have played a key role in driving pharmaceutical advancements, encompassing all areas of operations from bio-processing, manufacturing, packaging, drug distribution, formulations, and more.
Mr. Abir Mukherjee, the Founder and Managing Director of Glamac, expressed his thoughts on the company’s achievement, stating that they were thrilled when ET nominated them for the award and ecstatic to have won it. He acknowledged the trust and confidence of their clients and associates, without whom the award would not have been possible. According to him, the credit for the company’s success goes to their team’s dedication and hard work, who helped them achieve this significant milestone. Glamac’s focus is on continuous innovation and the development of research-backed products and formulations for the world, leveraging their global relationship network. He also highlighted that the company had made its mark in the industry since its inception with its next-generation nutritional solutions.
Glamac is a competent Veterinary Pharma organisation based in Mumbai (Thane, Maharashtra), with a focus on technically driven Veterinary Formulations. Its specialty is Poultry Nutrition and Feed Supplements. Glamac has established strategic sourcing channels by leveraging its strong relationships with organisations worldwide, including dynamic business tie-ups in Europe. For instance, the company has marketing partnerships with Xvet Germany and Herbonis, Switzerland, a firm that specialises in natural solutions for Animal Nutrition.
Glamac is a leading company in the market, known for its flagship product Glam-Sone, which is a growth promoter that doesn’t contain antibiotics. Along with Glam-Sone, Glamac offers other notable products such as Glam-Quindox, a highly effective solution for controlling E. Coli, the Cynka-Antidiarrheal range, Liptivo-XT-Nutritional Emulsifier, and the Glavitro-Anticoccidial range.
Glamac has recently brought to the Indian market the internationally acclaimed product Panbonis from Herbonis Switzerland, which is a natural and innovative solution for animal nutrition. It includes Vitamin D3 metabolites, which promote the development of strong bones and healthy eggs in chickens. This launch marked the beginning of Glamac’s efforts to improve the health and well-being of poultry through its nutrition solutions.
Glamac has been recognized for its outstanding efforts in the industry before, and this is not the first time. The organization was awarded the “Fastest Growing Indian Company Excellence Award” by the “International Achievers Conference” in 2019. Glamac is thankful to be part of a community that is enthusiastic about making a positive impact on the world. Winning the ETIPWA award is a great honor for Glamac, and it will inspire the team to work even harder to achieve excellence.